To print: Select File and then Print from your browser's menu
Getting Up to Speed on New Injection Guidelines (Part 1)
October 17, 2011
Chances are, if you’re reading this, you take (inject) insulin, or you know someone who does. Insulin injections aren’t a whole lot of fun, but then again, they aren’t the end of the world, either. Some people mind them more than others. There are those who have a real fear of any kind of injections, whereas others are more matter-of-fact about injecting themselves.
The reality is that insulin is pretty much the most effective medicine there is to manage blood glucose. That’s because the insulin that you inject into yourself is a replica of what your body would make naturally (if it could, or if it could make enough). Diabetes pills and other injectables can work very well, but over time, they tend to be less effective at controlling blood glucose. That’s because, if you have Type 2 diabetes, the diabetes changes over time. Also, remember that pills aren’t used to manage Type 1 diabetes, so anyone with Type 1 diabetes must inject insulin (via syringe, pen, or pump) in order to survive.
Today, people who take insulin have a few options for how they want to inject. Syringes are disposable, needles are much thinner and shorter, pens make things easier and more convenient, and for some, insulin pumps are the way to go.
“TITANs” of Injection Guidelines
Back in 2009, a group of diabetes experts from around the world convened in Greece as part of the Third Injection Technique workshop in AtheNs (TITAN). The group collaborated to develop newer, more specific injection guidelines to enable health-care professionals help their patients be more successful at giving injections. These guidelines address issues such as what sites to use, how to store insulin, how to properly inject, how to use an insulin pen, and how to dispose of sharps. You might be thinking, “What’s new and exciting about that?” but the reality is that prior to this meeting, guidelines were pretty vague and there wasn’t much consensus on some of these issues.
• Almost 50% of folks used an 8-millimeter (mm) or 5/16″-length needle
• 21% of people injected into the same site for a whole day or even several days
• Almost half of the people surveyed had symptoms of lipohypertrophy (build up of fatty tissue at the injection site due to repeatedly injecting into the same spot)
• Of the 65% who used NPH insulin, 35% did not mix it before injecting
If you can identify with any of the above, at least you know you’re not alone! Next week, I’ll review some key findings from the new injection guidelines, so stay tuned.
Disclaimer of Medical Advice:You understand that the blogs posts and comments to such blog posts (whether posted by us, our agents, bloggers, or by users) do not constitute medical advice or recommendation of any kind and you should not rely on any information contained on such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.